123 related articles for article (PubMed ID: 1826714)
41. Modulation of the immune response of Balb/c mice against Leishmania major by imuvert.
Taha SM; Tabbara KS
Int J Immunopharmacol; 1997 Aug; 19(8):443-9. PubMed ID: 9568550
[TBL] [Abstract][Full Text] [Related]
42. Stereotactic high-activity brachytherapy for malignant intra-axial brain tumors. Status report as of March, 1995.
Bernstein M; Laperriere N; Glen J
Stereotact Funct Neurosurg; 1995; 65(1-4):167-70. PubMed ID: 8916348
[TBL] [Abstract][Full Text] [Related]
43. Brachytherapy and hyperthermia for malignant astrocytomas.
Sneed PK; Larson DA; Gutin PH
Semin Oncol; 1994 Apr; 21(2):186-97. PubMed ID: 8153664
[No Abstract] [Full Text] [Related]
44. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
[TBL] [Abstract][Full Text] [Related]
45. A review of current and future treatment strategies for malignant astrocytomas in adults.
Nieder C; Nestle U
Strahlenther Onkol; 2000 Jun; 176(6):251-8. PubMed ID: 10897251
[TBL] [Abstract][Full Text] [Related]
46. Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas.
Glantz MJ; Choy H; Kearns CM; Cole BF; Mills P; Zuhowski EG; Saris S; Rhodes CH; Stopa E; Egorin MJ
J Clin Oncol; 1996 Feb; 14(2):600-9. PubMed ID: 8636777
[TBL] [Abstract][Full Text] [Related]
47. [Current problems in the diagnosis and treatment of malignant tumors of the brain according to findings in the foreign literature].
Romodanov AP; Rudiak KE
Vopr Neirokhir; 1976; (6):54-7. PubMed ID: 1014532
[No Abstract] [Full Text] [Related]
48. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
49. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
[TBL] [Abstract][Full Text] [Related]
50. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study.
Salazar AM; Levy HB; Ondra S; Kende M; Scherokman B; Brown D; Mena H; Martin N; Schwab K; Donovan D; Dougherty D; Pulliam M; Ippolito M; Graves M; Brown H; Ommaya A
Neurosurgery; 1996 Jun; 38(6):1096-103; discussion 1103-4. PubMed ID: 8727138
[TBL] [Abstract][Full Text] [Related]
51. Augmentation of ADCC and cytotoxic T-cell activity with ImuVert.
Warren RP; McCall CA; Urban RW
Mol Biother; 1989; 1(6):323-7. PubMed ID: 2610951
[TBL] [Abstract][Full Text] [Related]
52. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
[TBL] [Abstract][Full Text] [Related]
53. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Poisson M; Péréon Y; Chiras J; Delattre JY
J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.
Amatya VJ; Akazawa R; Sumimoto Y; Takeshima Y; Inai K
Pathol Int; 2009 Feb; 59(2):80-5. PubMed ID: 19154260
[TBL] [Abstract][Full Text] [Related]
55. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
[TBL] [Abstract][Full Text] [Related]
56. Synergism of ara-C-imuvert combination in aborting the development of transplanted chloroleukemia in the rat.
Hussein AM; Jimenez JJ; Hindahl M; Yunis AA
Am J Med Sci; 1991 Feb; 301(2):81-4. PubMed ID: 2012104
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of a biologic response modifier derived from Serratia marcescens: effects on feline macrophages and usefulness for the prevention and treatment of viremia in feline leukemia virus-infected cats.
Elmslie RE; Ogilvie GK; Dow SW; Gasper P; Hoover EA; Cooper MF; Pearson FC
Mol Biother; 1991 Dec; 3(4):231-8. PubMed ID: 1768375
[TBL] [Abstract][Full Text] [Related]
58. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.
Wallner KE; Galicich JH; Krol G; Arbit E; Malkin MG
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1405-9. PubMed ID: 2542195
[TBL] [Abstract][Full Text] [Related]
59. [A comparative study of the treatment of high grade gliomas].
Budke M; Isla-Guerrero A; Pérez-López C; Pérez-Alvarez M; García-Grande A; Bello MJ; Rey J
Rev Neurol; 2003 Nov 16-30; 37(10):912-6. PubMed ID: 14634918
[TBL] [Abstract][Full Text] [Related]
60. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas?
Massimino M; Cohen KJ; Finlay JL
Pediatr Blood Cancer; 2010 Apr; 54(4):641-3. PubMed ID: 20146219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
